Subcutaneous use of treprostinil in pediatric pulmonary hypertension patients: A report of three cases

被引：0

作者：

Kavgaci, Akif ^{[1
]}

Kula, Serdar ^{[1
]}

Incedere, Fatma ^{[1
]}

Terlemez, Semiha ^{[1
]}

Tunaoglu, Fatma Sedef ^{[1
]}

机构：

[1] Gazi Univ, Fac Med, Dept Pediat, Div Pediat Cardiol, Ankara, Turkiye

来源：

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2023年 / 31卷 / 01期

关键词：

Pulmonary arterial hypertension; subcutaneous; treprostinil;

D O I：

10.5606/tgkdc.dergisi.2023.23748

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Treprostinil was approved by the United States Food and Drug Administration for use in the treatment of pulmonary arterial hypertension in 2002. Intravenous or subcutaneous treprostinil is used in pulmonary arterial hypertension patients in the functional classes of II-IV to alleviate exercise-related symptoms, or in cases where epoprostenol treatment should be reduced due to side effects. In this article, we describe three pediatric cases of pulmonary arterial hypertension in whom subcutaneous treprostinil was used.

引用

页码：145 / 148

页数：4

共 50 条

[1] Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
McSweeney, Julia
Colglazier, Elizabeth
Becerra, Jasmine
Leary, Brienne
Miller-Reed, Kathleen
Walker, Stephen
Tillman, Katy
Magness, Melissa
Ogawa, Michelle
Bannon, Whitney
Kivett, Tisha
Jackson, Emma O. O.
Davis, Anne
Shepard, Cathy
Richards, Susan
Whalen, Elise
Engstrand, Shannon
DiPasquale, Zachary
Connor, Jean A. A.
PULMONARY CIRCULATION, 2023, 13 (02)
[2] Subcutaneous treprostinil in pediatric pulmonary arterial hypertension.
Bajolle, F.
Levy, M.
Szezepanski, I.
Bonnet, D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
[3] Add-On Therapy with Subcutaneous Treprostinil for Refractory Pediatric Pulmonary Hypertension
Levy, Marilyne
Celermajer, David S.
Bourges-Petit, Elisabeth
Del Cerro, Maria-Jesus
Bajolle, Fanny
Bonnet, Damien
JOURNAL OF PEDIATRICS, 2011, 158 (04): : 584 - 588
[4] Treprostinil transition from subcutaneous to intravenous in pediatric patients with Pulmonary Hypertension undergoing a risky procedure.
Bustamante, Gina
Diez, Ana
Torrent, Alba
Morillo, Maria
Iglesias, Ignacio
Rovira, Sandra
Pujol, Montserrat
Moreno, Antonio
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[5] Tolerability and Efficacy of Subcutaneous Treprostinil Therapy in Patients with Pulmonary Arterial Hypertension
Hatano, Masaru
Maki, Hisataka
Minatsuki, Shun
Komuro, Issei
JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S193 - S193
[6] USE OF SUBCUTANEOUS TREPROSTINIL IN PEDIATRIC PULMONARY ARTERIAL HYPERTENSION - BRIDGE-TO-TRANSPLANT OR LONG-TERM TREATMENT?
Ablonczy, L.
PEDIATRIC TRANSPLANTATION, 2017, 21 : 11 - 11
[7] Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension
Levy, Marilyne
Del Cerro, Maria-Jesus
Nadaud, Sophie
Vadlamudi, Karunakar
Colgazier, Elizabeth
Fineman, Jeff
Bonnet, Damien
Adatia, Ian
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 153 - 157
[8] Pulmonary thromboendarterectomy in pediatric patients: Report of three cases
Kumbasar, Ulas
Aypar, Ebru
Karagoz, Tevfik
Demircin, Metin
Dogan, Riza
TURKISH JOURNAL OF PEDIATRICS, 2018, 60 (05) : 604 - 607
[9] Real-life evidence of the use of subcutaneous treprostinil in pulmonary hypertension in Argentina
Adrian Lescano, A.
Vargas Mieles, P. V. M. Paul Enrique
Guillermo Giacommi, G.
Cristian Botta, C. B.
Julieta Soricetti, J. S.
Manuel Rodriguez, M. R.
Fabian Diez, F. D.
Sorasio, G.
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 262 - 263
[10] Use of Treprostinil in Pediatric Pulmonary Hypertension: Case Reports and Review of the Literature
Gavotto, Arthur
Thomas, Fanny
Werner, Oscar
Moreau, Johan
Amedro, Pascal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (01) : 23 - 31

← 1 2 3 4 5 →